| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |